Logo image of SST

SYSTEM1 INC (SST) Stock Fundamental Analysis

NYSE:SST - US87200P1093 - Common Stock

7.59 USD
-0.18 (-2.32%)
Last: 9/8/2025, 12:20:18 PM
Fundamental Rating

2

Taking everything into account, SST scores 2 out of 10 in our fundamental rating. SST was compared to 69 industry peers in the Interactive Media & Services industry. SST may be in some trouble as it scores bad on both profitability and health. SST is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

SST had negative earnings in the past year.
In the past year SST had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: SST reported negative net income in multiple years.
In multiple years SST reported negative operating cash flow during the last 5 years.
SST Yearly Net Income VS EBIT VS OCF VS FCFSST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M

1.2 Ratios

With a Return On Assets value of -16.55%, SST is not doing good in the industry: 71.01% of the companies in the same industry are doing better.
The Return On Equity of SST (-122.41%) is worse than 81.16% of its industry peers.
Industry RankSector Rank
ROA -16.55%
ROE -122.41%
ROIC N/A
ROA(3y)-28.68%
ROA(5y)-8.81%
ROE(3y)-119.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SST Yearly ROA, ROE, ROICSST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

SST's Gross Margin of 43.75% is on the low side compared to the rest of the industry. SST is outperformed by 68.12% of its industry peers.
SST's Gross Margin has improved in the last couple of years.
SST does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.16%
GM growth 5Y6.51%
SST Yearly Profit, Operating, Gross MarginsSST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

2

2. Health

2.1 Basic Checks

SST does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SST has less shares outstanding
The number of shares outstanding for SST has been increased compared to 5 years ago.
Compared to 1 year ago, SST has a worse debt to assets ratio.
SST Yearly Shares OutstandingSST Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M
SST Yearly Total Debt VS Total AssetsSST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

SST has an Altman-Z score of -2.23. This is a bad value and indicates that SST is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -2.23, SST is not doing good in the industry: 76.81% of the companies in the same industry are doing better.
The Debt to FCF ratio of SST is 83.49, which is on the high side as it means it would take SST, 83.49 years of fcf income to pay off all of its debts.
SST has a Debt to FCF ratio (83.49) which is in line with its industry peers.
SST has a Debt/Equity ratio of 4.17. This is a high value indicating a heavy dependency on external financing.
SST has a Debt to Equity ratio of 4.17. This is amonst the worse of the industry: SST underperforms 86.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.17
Debt/FCF 83.49
Altman-Z -2.23
ROIC/WACCN/A
WACC9.4%
SST Yearly LT Debt VS Equity VS FCFSST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

SST has a Current Ratio of 1.18. This is a normal value and indicates that SST is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.18, SST is doing worse than 72.46% of the companies in the same industry.
SST has a Quick Ratio of 1.18. This is a normal value and indicates that SST is financially healthy and should not expect problems in meeting its short term obligations.
SST has a Quick ratio of 1.18. This is in the lower half of the industry: SST underperforms 72.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.18
SST Yearly Current Assets VS Current LiabilitesSST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

4

3. Growth

3.1 Past

SST shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.31%.
SST shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.76%.
Measured over the past years, SST shows a decrease in Revenue. The Revenue has been decreasing by -3.34% on average per year.
EPS 1Y (TTM)-0.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.32%
Revenue 1Y (TTM)-12.76%
Revenue growth 3Y-20.65%
Revenue growth 5Y-3.34%
Sales Q2Q%-17.41%

3.2 Future

SST is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.59% yearly.
Based on estimates for the next years, SST will show a very strong growth in Revenue. The Revenue will grow by 31.95% on average per year.
EPS Next Y10.42%
EPS Next 2Y1.01%
EPS Next 3Y26.96%
EPS Next 5Y15.59%
Revenue Next Year-15.98%
Revenue Next 2Y-2.91%
Revenue Next 3Y52.46%
Revenue Next 5Y31.95%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SST Yearly Revenue VS EstimatesSST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
SST Yearly EPS VS EstimatesSST Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -5 -10 -15 -20

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SST. In the last year negative earnings were reported.
Also next year SST is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SST Price Earnings VS Forward Price EarningsSST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

68.12% of the companies in the same industry are more expensive than SST, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SST indicates a somewhat cheap valuation: SST is cheaper than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 23.9
EV/EBITDA 15.31
SST Per share dataSST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as SST's earnings are expected to grow with 26.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.01%
EPS Next 3Y26.96%

0

5. Dividend

5.1 Amount

No dividends for SST!.
Industry RankSector Rank
Dividend Yield N/A

SYSTEM1 INC

NYSE:SST (9/8/2025, 12:20:18 PM)

7.59

-0.18 (-2.32%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners43.22%
Inst Owner Change-90.53%
Ins Owners35.04%
Ins Owner Change3.31%
Market Cap75.29M
Analysts80
Price Target10.2 (34.39%)
Short Float %7.07%
Short Ratio1.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.84%
Min EPS beat(2)15.08%
Max EPS beat(2)40.59%
EPS beat(4)3
Avg EPS beat(4)14.45%
Min EPS beat(4)-16.08%
Max EPS beat(4)40.59%
EPS beat(8)7
Avg EPS beat(8)28.68%
EPS beat(12)9
Avg EPS beat(12)15.6%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.52%
Min Revenue beat(2)5.45%
Max Revenue beat(2)5.58%
Revenue beat(4)3
Avg Revenue beat(4)-1.36%
Min Revenue beat(4)-18%
Max Revenue beat(4)5.58%
Revenue beat(8)7
Avg Revenue beat(8)0.33%
Revenue beat(12)8
Avg Revenue beat(12)0.67%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-80%
PT rev (3m)100%
EPS NQ rev (1m)-6.92%
EPS NQ rev (3m)-969.23%
EPS NY rev (1m)3.16%
EPS NY rev (3m)-671.54%
Revenue NQ rev (1m)-3.26%
Revenue NQ rev (3m)-20.37%
Revenue NY rev (1m)-6.38%
Revenue NY rev (3m)-6.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF 23.9
P/OCF 8.1
P/B 1.3
P/tB N/A
EV/EBITDA 15.31
EPS(TTM)-9.63
EYN/A
EPS(NY)-10.48
Fwd EYN/A
FCF(TTM)0.32
FCFY4.18%
OCF(TTM)0.94
OCFY12.35%
SpS31.96
BVpS5.85
TBVpS-22.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.55%
ROE -122.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.75%
FCFM 0.99%
ROA(3y)-28.68%
ROA(5y)-8.81%
ROE(3y)-119.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.16%
GM growth 5Y6.51%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 4.17
Debt/FCF 83.49
Debt/EBITDA 13.44
Cap/Depr 7.59%
Cap/Sales 1.94%
Interest Coverage N/A
Cash Conversion 51.67%
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.18
Altman-Z -2.23
F-Score5
WACC9.4%
ROIC/WACCN/A
Cap/Depr(3y)8.03%
Cap/Depr(5y)23.1%
Cap/Sales(3y)1.69%
Cap/Sales(5y)1.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.32%
EPS Next Y10.42%
EPS Next 2Y1.01%
EPS Next 3Y26.96%
EPS Next 5Y15.59%
Revenue 1Y (TTM)-12.76%
Revenue growth 3Y-20.65%
Revenue growth 5Y-3.34%
Sales Q2Q%-17.41%
Revenue Next Year-15.98%
Revenue Next 2Y-2.91%
Revenue Next 3Y52.46%
Revenue Next 5Y31.95%
EBIT growth 1Y33.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year150.66%
EBIT Next 3Y63.02%
EBIT Next 5Y36.17%
FCF growth 1Y-16.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.3%
OCF growth 3YN/A
OCF growth 5YN/A